Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYST-HD: Cysteamine in Huntington's Disease
NCT02101957Phase 3Unknown
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Oct 2010
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cysteamine in Huntington's disease (HD), sponsored by Centre Hospitalier Universitaire d'Angers. Status: unknown.
02
Drugs
cysteamine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT02101957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101957.